金城医药实际控制人收到行政处罚事先告知书

Core Points - The company Jin Cheng Pharmaceutical (300233.SZ) has received a notice from its actual controller and chairman, Zhao Yeqing, regarding an administrative penalty proposed by the China Securities Regulatory Commission (CSRC) for alleged violations of the Securities Law [1] - The proposed penalties include fines totaling 3 million yuan, with Zhao Yeqing responsible for 1.5 million yuan, Wang Zhen for 1.2 million yuan, and Liu Feng for 300,000 yuan [1] - Additionally, Zhao Yeqing is subject to a 4-year market ban, while Wang Zhen faces a 3-year ban, preventing them from engaging in securities business or holding positions in any listed or non-listed public companies during the ban period [1] Summary of Related Sections - Administrative Penalty Details: The CSRC has issued a notice indicating that Zhao Yeqing, Wang Zhen, and Liu Feng are suspected of manipulating the securities market, which constitutes a violation of the Securities Law [1] - Financial Implications: The total fines amount to 3 million yuan, with specific allocations for each individual involved [1] - Market Ban Regulations: The market bans imposed on Zhao Yeqing and Wang Zhen restrict their ability to participate in securities-related activities for the specified duration [1][2]